Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types
暂无分享,去创建一个
Christopher R. Heery | James L. Gulley | Jacob Richards | Ravi A. Madan | J. Schlom | R. Madan | J. Gulley | R. Donahue | Jacob Richards | C. Heery | Jeffrey Schlom | Italia Grenga | Renee N. Donahue | Lauren M. Lepone | I. Grenga | Simon Metenou | S. Metenou | J. Richards | Simon Metenou
[1] Greg Finak,et al. State‐of‐the‐Art in the Computational Analysis of Cytometry Data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[2] Feng Jiang,et al. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer , 2015, Laboratory Investigation.
[3] G. Acharya,et al. Gene expression profile in cardiovascular disease and preeclampsia: a meta-analysis of the transcriptome based on raw data from human studies deposited in Gene Expression Omnibus. , 2015, Placenta.
[4] I. Lossos,et al. HGAL localization to cell membrane regulates B-cell receptor signaling. , 2015, Blood.
[5] Ruth R. Montgomery,et al. CyTOF supports efficient detection of immune cell subsets from small samples. , 2014, Journal of immunological methods.
[6] I. Lowy,et al. Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab , 2014, Journal of Immunotherapy for Cancer.
[7] L. Sengeløv,et al. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer , 2014, Cancer Immunology, Immunotherapy.
[8] V. Bronte,et al. Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.
[9] P. Dessen,et al. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation , 2014, The Journal of experimental medicine.
[10] S. Steinberg,et al. A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates , 2014, Cancer Immunology, Immunotherapy.
[11] C. Castelo-Branco,et al. The immune system and aging: a review , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[12] E. Plimack,et al. PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection , 2013, Cancer Immunology Research.
[13] J. Kuiper,et al. T-Cell Immunoglobulin and Mucin Domain 3 Acts as a Negative Regulator of Atherosclerosis , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[14] D. Serraino,et al. Cancer, aging and immune reconstitution. , 2013, Anti-cancer agents in medicinal chemistry.
[15] George C Tseng,et al. Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis , 2013, Science Translational Medicine.
[16] F. Guadagni,et al. Effects of conventional therapeutic interventions on the number and function of regulatory T cells , 2013, Oncoimmunology.
[17] H. Groen,et al. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients. , 2013, Lung cancer.
[18] M. Calaminici,et al. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] C. Verschoor,et al. Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer , 2013, Journal of leukocyte biology.
[20] L. Xerri,et al. PD-1 is a novel regulator of human B-cell activation. , 2013, International immunology.
[21] I. Lowy,et al. T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment , 2013, Cancer Immunology, Immunotherapy.
[22] T. Greten,et al. Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies , 2013, Cancer Immunology, Immunotherapy.
[23] S. Wong,et al. Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins , 2013, The Journal of Immunology.
[24] A. Larbi,et al. NK Cells in Healthy Aging and Age-Associated Diseases , 2012, Journal of biomedicine & biotechnology.
[25] G. Shurin,et al. Tumor associated regulatory dendritic cells. , 2012, Seminars in cancer biology.
[26] J. Paul Robinson,et al. Computational analysis of high-throughput flow cytometry data , 2012, Expert opinion on drug discovery.
[27] P. Chattopadhyay,et al. Cytometry: today's technology and tomorrow's horizons. , 2012, Methods.
[28] S. Kuhara,et al. Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination , 2012, Cancer.
[29] J. Schlom,et al. Clinical evaluation of TRICOM vector therapeutic cancer vaccines. , 2012, Seminars in oncology.
[30] Kanji Takahashi,et al. Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection. , 2012, The Journal of surgical research.
[31] H. Pircher,et al. Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization , 2012, PLoS ONE.
[32] Regina K. Cheung,et al. Screening: CyTOF—the next generation of cell detection , 2011, Nature Reviews Rheumatology.
[33] A. Pera,et al. Immunosenescence of Human Natural Killer Cells , 2011, Journal of Innate Immunity.
[34] Randall E. Brand,et al. Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility , 2011, PloS one.
[35] D. Tran,et al. T regulatory cells in cancer: recent advances and therapeutic potential , 2010, Expert opinion on biological therapy.
[36] Björn Nilsson,et al. Integrative genomic analysis of HIV-specific CD8+ T cells reveals that PD-1 inhibits T cell function by upregulating BATF , 2010, Nature Medicine.
[37] Mario Roederer,et al. OMIPs—Orchestrating multiplexity in polychromatic science , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[38] P. Debré,et al. Human NK cells display major phenotypic and functional changes over the life span , 2010, Aging cell.
[39] R. Yung,et al. Leukocyte function in the aging immune system , 2010, Journal of leukocyte biology.
[40] A. Goldrath,et al. Surviving the crash: transitioning from effector to memory CD8+ T cell. , 2009, Seminars in immunology.
[41] C. Galustian,et al. The effect of colorectal cancer upon host peripheral immune cell function , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[42] J. Ouslander,et al. T cell subset-specific susceptibility to aging. , 2008, Clinical immunology.
[43] G. Freeman,et al. PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.
[44] J. Schlom,et al. Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer , 2008, Clinical Cancer Research.
[45] T. Whiteside,et al. The Frequency and Suppressor Function of CD4+CD25highFoxp3+ T Cells in the Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck , 2007, Clinical Cancer Research.
[46] Águeda Martínez-Barriocanal,et al. Molecular and Functional Characterization of CD300b, a New Activating Immunoglobulin Receptor Able to Transduce Signals through Two Different Pathways1 , 2006, The Journal of Immunology.
[47] L. Walker,et al. The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology , 2006, Immunological reviews.
[48] T. Whiteside,et al. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. , 2006, Seminars in cancer biology.
[49] Takuma Hayashi,et al. CD72‐mediated suppression of human naive B cell differentiation by down‐regulating X‐box bindingprotein 1 , 2005, European journal of immunology.
[50] P. Moss,et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age , 2005, Clinical and experimental immunology.
[51] D. E. Faunce,et al. Aging and innate immune cells , 2004, Journal of leukocyte biology.
[52] P. Chattopadhyay,et al. Seventeen-colour flow cytometry: unravelling the immune system , 2004, Nature Reviews Immunology.
[53] C. Stăvaru,et al. Evidence for immune defects in breast and lung cancer patients , 2004, Cancer Immunology, Immunotherapy.
[54] R. Feise. Do multiple outcome measures require p-value adjustment? , 2002, BMC medical research methodology.
[55] P. Debré,et al. Aiolos and Ikaros: Regulators of lymphocyte development, homeostasis and lymphoproliferation , 2002, Apoptosis.
[56] A. Barclay,et al. CD200 and membrane protein interactions in the control of myeloid cells. , 2002, Trends in immunology.
[57] K. Hirokawa,et al. Altered T cell signalling in ageing , 2001, Mechanisms of Ageing and Development.
[58] F. Borrego,et al. NK phenotypic markers and IL2 response in NK cells from elderly people , 1999, Experimental Gerontology.
[59] H. Müller-Hermelink,et al. Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.
[60] R. Scheuermann,et al. Elucidation of seventeen human peripheral blood B‐cell subsets and quantification of the tetanus response using a density‐based method for the automated identification of cell populations in multidimensional flow cytometry data , 2010, Cytometry. Part B, Clinical cytometry.
[61] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[62] M. Fujimoto,et al. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. , 2005, Current directions in autoimmunity.
[63] P. Kralickova,et al. CD4+ T-lymphocytopenia and systemic immune activation in patients with primary and secondary liver tumours. , 2001, Scandinavian journal of clinical and laboratory investigation.
[64] S. Sato,et al. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. , 1997, Annual review of immunology.